Jesse E. Brunsveld
Utrecht, UT 3584CT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Exploring intrinsic variability between cultured nasal and bronchial epithelia in cystic fibrosis.
Journal: Scientific reports
Published: April 18, 2023
High-throughput functional assay in cystic fibrosis patient-derived organoids allows drug repurposing.
Journal: ERJ open research
Published: September 28, 2022
FDA-approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypes.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: September 13, 2022
Measuring cystic fibrosis drug responses in organoids derived from 2D differentiated nasal epithelia.
Journal: Life science alliance
Published: November 26, 2021
Forskolin induced swelling (FIS) assay in intestinal organoids to guide eligibility for compassionate use treatment in a CF patient with a rare genotype.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: November 07, 2021
Forskolin-induced organoid swelling is associated with long-term cystic fibrosis disease progression.
Journal: The European respiratory journal
Published: February 17, 2021
Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoids.
Journal: Life science alliance
Published: October 19, 2020
CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank.
Journal: Cell stem cell
Published: July 02, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026